Khokher Waleed, Iftikhar Saffa, Abrahamian Andrew, Beran Azizullah, Abuhelwa Ziad, Rashid Rakin, Ali Hyder, Khuder Sadik, Assaly Ragheb
Department of Internal Medicine, University of Toledo, Toledo, OH 43606, USA.
Department of Medicine, University of Kansas St Francis Health, Topeka, KS 66606, USA.
J Clin Med. 2023 Feb 17;12(4):1617. doi: 10.3390/jcm12041617.
Coronavirus disease 2019 (COVID-19) caused significant morbidity and mortality worldwide. There is limited information describing the hospital outcomes of COVID-19 patients in regard to specific body mass index (BMI) categories.
We utilized the Healthcare Cost and Utilization Project Nationwide Inpatient Sample (NIS) 2020 database to collect information on patients hospitalized for COVID-19 in the United States. Using the International Classification of Diseases, 10th revision, Clinical Modification (ICD-10-CM) coding system, adult patients (≥18 years of age) with a primary hospitalization for COVID-19 were identified. Adjusted analyses were performed to assess for mortality, morbidity, and resource utilization, and compare the outcomes among patients categorized according to BMI.
A total of 305,284 patients were included in this study. Of them, 248,490 had underlying obesity, defined as BMI ≥ 30. The oldest patients were observed to have BMI < 19, while youngest patients were in the BMI > 50 category. BMI < 19 category had the highest crude in-hospital mortality rate. However, after adjusted regression, patients with BMI > 50 (adjusted odds ratio (aOR) 1.63, 95% CI 1.48-1.79, -value < 0.001) had the highest increased odds, at 63%, of in-hospital mortality compared to all other patients in the study. Patients with BMI > 50 also had the highest increased odds of needing invasive mechanical ventilation (IMV) and mortality associated with IMV compared to all other patient, by 37% and 61%, respectively. Obese patients were noted to have shorter average hospital length of stay (LOS), by 1.07 days, compared to non-obese patients, but there was no significant difference in average hospitalization charges.
Among obese patients primarily hospitalized with COVID-19, those with BMI ≥ 40 had significantly increased rates of all-cause in-hospital mortality, need for IMV, mortality associated with IMV, and septic shock. Overall, obese patients had shorter average hospital LOS, however, did not have significantly higher hospitalization charges.
2019冠状病毒病(COVID-19)在全球范围内造成了严重的发病和死亡。关于COVID-19患者在特定体重指数(BMI)类别方面的医院结局的信息有限。
我们利用2020年医疗保健成本和利用项目全国住院患者样本(NIS)数据库收集美国因COVID-19住院患者的信息。使用国际疾病分类第10版临床修订本(ICD-10-CM)编码系统,确定以COVID-19为主因住院的成年患者(≥18岁)。进行了调整分析以评估死亡率、发病率和资源利用情况,并比较根据BMI分类的患者之间的结局。
本研究共纳入305,284例患者。其中,248,490例患有基础肥胖,定义为BMI≥30。观察到年龄最大的患者BMI<19,而年龄最小的患者BMI>50。BMI<19组的粗住院死亡率最高。然而,经过调整回归后,BMI>50的患者(调整后的优势比(aOR)为1.63,95%可信区间为1.48-1.79,P值<0.001)与研究中的所有其他患者相比,住院死亡率增加的几率最高,为63%。与所有其他患者相比,BMI>50的患者需要有创机械通气(IMV)以及与IMV相关的死亡的几率也分别最高,增加了37%和61%。与非肥胖患者相比,肥胖患者的平均住院时间缩短了1.07天,但平均住院费用没有显著差异。
在主要因COVID-19住院的肥胖患者中,BMI≥40的患者全因住院死亡率、IMV需求、与IMV相关的死亡率和感染性休克的发生率显著增加。总体而言,肥胖患者的平均住院时间较短,但住院费用没有显著更高。